Skip to content

CDR

NPC examines CER as health reform takes hold

By the close of 2012 two key questions regarding the Affordable Care Act were finally addressed: one, whether the health care reform law is constitutional and, two, whether it would be repealed under a new administration.

2013 Outlook: Retail Rx embraces change

2013 Outlook: Retail Rx embraces change

Chain drug executives are sounding an upbeat tone as they size up their prospects for 2013. Though most executives express concern about fiscal developments in Washington, they are confident in the outlook for the retail pharmacy industry.

Rite Aid’s Thompson honored as top pharmacy exec

Rite Aid’s Thompson honored as top pharmacy exec

For his leadership in marshalling his team and executing a well-thought-out pharmacy plan, Rite Aid Corp. executive vice president of pharmacy Robert Thompson has been named Pharmacy Executive of the Year by Chain Drug Review. Pharmacists at Rite Aid are making a bigger commitment to health care.

Sanofi’s Chattem acquires Rolaids

Chattem Inc., the U.S. consumer health division of Sanofi, has completed the acquisition of the worldwide rights to the Rolaids antacid brand from the McNeil Consumer Healthcare Division of McNeil-PPC Inc.

Boehringer Ingelheim tool helps improve Rx adherence

Just as no two patients are alike, no single strategy should serve as the approach to improving medication adherence. That’s one of the principles behind the Patient Empowerment Program (PEP) that can be used by pharmacists to help improve compliance.

<i>CDR</i> names Wasson, Pessina Retailers of Year

When the editors of Chain Drug Review looked back at 2012 with an eye toward identifying the executives who had the biggest impact on the industry, one event and the people behind it clearly stood out: the unprecedented partnership Walgreen Co.

Rite Aid’s Thompson tabbed top pharmacy exec

Pharmacists at Rite Aid Corp. are making a bigger commitment to health care. Embracing a broader role, the drug chain’s pharmacy team is on a mission to not just provide vital medications but also help the people and the communities they serve improve their overall health and wellness.

2013 Outlook: Retail pharmacy embraces change

2013 Outlook: Retail pharmacy embraces change

Chain drug executives are sounding an upbeat tone as they size up their prospects for 2013. Though most executives express concern about fiscal developments in Washington, they are confident in the outlook for the retail pharmacy industry.

Big stride made in turnaround at Rite Aid

Rite Aid Corp. reported its first quarterly profit since May 2007, thanks largely to generic drug sales that bolstered gross margin as well as improved front-end sales. The bottom line for the 13-week fiscal 2013 third quarter ended December 1 swung to a net profit of $61.9 million, or 7 cents

New CEO takes helm at CACDS

Denise Carpenter has been named president and chief executive officer of the Canadian Association of Chain Drug Stores. Before joining CACDS, she served as president and CEO of the Canadian Nuclear Association (CNA) from 2009 to 2012.